Role of miR-139 as a surrogate marker for tumor aggression in breast cancer

Hongyan Dai, Dan Gallagher, Sarah Schmitt, Ziyan Y. Pessetto, Fang Fan, Andrew K. Godwin, Ossama Tawfik

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

MicroRNAs are non–protein coding molecules that play a key role in oncogenesis, tumor progression, and metastasis in many types of malignancies including breast cancer. In the current study, we studied the expression of microRNA-139-5p (miR-139) in invasive ductal carcinoma (IDC) of the breast and correlated its expression with tumor grade, molecular subtype, hormonal status, human epidermal growth factor receptor 2 status, proliferation index, tumor size, lymph node status, patient's age, and overall survival in 74 IDC cases. In addition, we compared and correlated miR-139 expression in 18 paired serum and tissue samples from patients with IDC to assess its value as a serum marker. Our data showed that miR-139 was down-regulated in all tumor tissue samples compared with control. More pronounced down-regulation was seen in tumors that were higher grade, estrogen receptor negative, progesterone receptor negative, more proliferative, or larger in size (P <.05). Although not statistically significant, lower miR-139 level was frequently associated with human epidermal growth factor receptor 2 overexpression. In addition, significantly lower miR-139 tissue level was seen in patients who were deceased (P =.027), although older age (>50 years) and positive local nodal disease did not adversely affect miR-139 expression. In contrast, serum miR-139 profile of the patients appeared similar to that of normal control. In conclusion, our study demonstrated that down-regulation of miR-139 was associated with aggressive tumor behavior and disease progression in breast cancer. miR-139 may serve as a risk assessment biomarker in tailoring treatment options.

Original languageEnglish
Pages (from-to)68-77
Number of pages10
JournalHuman Pathology
Volume61
DOIs
StatePublished - 1 Mar 2017
Externally publishedYes

Keywords

  • Breast cancer
  • Invasive ductal carcinoma
  • Micro RNA
  • MicroRNA-139
  • Oncogenesis
  • Tumor progression

Fingerprint

Dive into the research topics of 'Role of miR-139 as a surrogate marker for tumor aggression in breast cancer'. Together they form a unique fingerprint.

Cite this